#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Post transplant lymphoproliferative disorder Pancreatic carcinoma Transferrin decreased Ewing's sarcoma metastatic Neuroendocrine carcinoma Biliary neoplasm Progressive familial intrahepatic cholestasis Dermatomyositis Juvenile idiopathic arthritis Neuroendocrine carcinoma metastatic Paraneoplastic neurological syndrome Transient ischaemic attack Cutaneous calcification Spinal muscular atrophy Leukodystrophy More trials…

    Learn about Rare Diseases

    Angiosarcoma – Basic Information Ehlers-Danlos syndrome Gastrointestinal stromal tumour – Life with Disease Fabry’s disease – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Life with Disease Encephalitis autoimmune – Trials in Disease Osteosarcoma metastatic – Diagnostics Cystic fibrosis lung – Trials in Disease Progressive supranuclear palsy – Trials in Disease Hairy cell leukaemia recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tofacitinib Citrate Dexamethasone Ph. Eur. Methotrexate Sodium Formoterol Fumarate Dihydrate Rbl007.2 Cefalexin Cefoxitin GSKVX000000040033 Amisulpride TUVATEXIB Budigalimab Thiamazole Tx200-Tr101 Fasudil Hydrochloride NALOXEGOL Promethazine Hydrochloride AVTX-009 Clobetasol Propionate Sodium Chloride Solution 0.9% Tapentadol Hydrochloride More therapies…

    Learn about Your Condition

    Colour blindness Morning sickness Tuberous sclerosis complex Spinal cord injury cervical Suicidal ideation Diabetic ketoacidosis Endocarditis bacterial Transient ischaemic attack Lichenoid keratosis Inguinal hernia Cardiac arrest Complex regional pain syndrome Penile cancer Urinary tract infection Agitation postoperative More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hormonal diseases

  • Study on Morphine, Lidocaine, and Naloxone for Patients with Obesity and Sleep Apnea

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Metabolic surgery
    Investigated Drugs:
    • Naloxone Hydrochloride
    • Morphine Hydrochloride
    • Lidocaine Hydrochloride
    Denmark

  • Study on How Elinzanetant Affects Dabigatran Etexilate in Healthy Volunteers with Vasomotor Symptoms

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Testosterone deficiency syndrome
    Investigated Drugs:
    • Dabigatran Etexilate
    • Elinzanetant
    Germany

  • Study to Identify Patients at Risk of Bone Disease from Glucocorticoids Using Prednisolone and Placebo

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Osteoporosis
    Investigated Drugs:
    • Placebo
    • Prednisolone
    Denmark

  • Study on Insulin Aspart for Recovery from Low Blood Sugar in People with and without Type 2 Diabetes

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Insulin Aspart
    Austria

  • Study on Hydrocortisone for Stress in Patients with Polymyalgia Rheumatica or Giant Cell Arteritis and Adrenal Insufficiency

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Adrenal insufficiency
    Investigated Drugs:
    • Hydrocortisone
    Denmark

  • Study on the Effects and Safety of Lutropin Alfa and hCG in Men with Hypogonadotropic Hypogonadism

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Hypogonadism male
    Investigated Drugs:
    • Lutropin Alfa
    Italy
Previous Page
1 … 13 14 15 16 17 … 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!